The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
Open Access
- 24 January 2008
- journal article
- Published by Springer Nature in BMC Cell Biology
- Vol. 9 (1) , 4
Abstract
A crucial event in Prostate Cancer progression is the conversion from a hormone-sensitive to a hormone-refractory disease state. Correlating with this transition, androgen receptor (AR) amplification and mutations are often observed in patients failing hormonal ablation therapies. β-Catenin, an essential component of the canonical Wnt signaling pathway, was shown to be a coactivator of the AR signaling in the presence of androgens. However, it is not yet clear what effect the increased levels of the AR could have on the Wnt signaling pathway in these hormone-refractory prostate cells.Keywords
This publication has 57 references indexed in Scilit:
- Time course of serum testosterone and luteinizing hormone levels after cessation of long‐term luteinizing hormone‐releasing hormone agonist treatment in patients with prostate cancerThe Prostate, 2005
- Bioactivity of Androgens Within the Testes and Serum of Normal MenJournal of Andrology, 2005
- Wnt signalling in stem cells and cancerNature, 2005
- Wnt signalling and prostate cancerProstate Cancer and Prostatic Diseases, 2005
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- Expression of Concern: Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinomaCancer, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Wnt Signaling Induces the Myogenic Specification of Resident CD45+ Adult Stem Cells during Muscle RegenerationCell, 2003
- β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent TranscriptionMolecular and Cellular Biology, 2003
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990